Kenza Health Hub logoGet Started

Table of contents

IndicationsComposition, forms, route of administrationDose and vaccination scheduleContra-indications, adverse effects, precautions
1 May 2026Vaccines, immunoglobulins and antisera

Meningococcal A+C Vaccine: Schedule and Precautions

Meningococcal A+C vaccine guidance for outbreaks and higher-risk travel in hyperendemic areas.

Also searched as

MenAC vaccine

Source reviewed

source date listed on the source page

Guide category

Vaccines, immunoglobulins and antisera

Safety boundary

Educational medicine information, not personal medical advice.

Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.

This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Indications

  • Prevention of meningitis due to meningococci groups A and C in mass immunisation campaigns during outbreaks due to meningococcus A or C.
  • Prevention for travellers spending more than 1 month in hyperendemic areas.

Composition, forms, route of administration

  • Inactivated bacterial polysaccharide vaccine.
  • Powder for injection in monodose or multidose vial, to be dissolved with the entire vial of the diluent supplied by the manufacturer.
  • For deep SC or IM injection into the deltoid muscle or the anterolateral part of the thigh in children, following the manufacturer's instructions.

Dose and vaccination schedule

  • Child from 2 years and adult: 0.5 ml single dose.

Contra-indications, adverse effects, precautions

  • Do not administer to patients with history of allergic reaction to a previous injection of meningococcal vaccine.
  • Vaccination should be postponed in the event of severe acute febrile illness; minor infections are not contra-indications.
  • May cause mild local reaction and mild fever.
  • Do not mix with other vaccines in the same syringe.
  • If administered simultaneously with EPI vaccines, use different syringes and injection sites.
  • Pregnancy and breast-feeding: no contra-indication.
  • Immunity develops 7 to 10 days after injection and lasts approximately 3 years.

Source

MSF Essential drugs practical guidelines (January 2026)

This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.

Rate this guide

Be the first to rate this guide.